
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cutaneous T‐cell lymphoma following dupilumab use: a systematic review
Ariel Park, Lulu Wong, Annalise Lang, et al.
International Journal of Dermatology (2022) Vol. 62, Iss. 7, pp. 862-876
Open Access | Times Cited: 41
Ariel Park, Lulu Wong, Annalise Lang, et al.
International Journal of Dermatology (2022) Vol. 62, Iss. 7, pp. 862-876
Open Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies
Dawn Marie R. Davis, Aaron M. Drucker, Ali Alikhan, et al.
Journal of the American Academy of Dermatology (2023) Vol. 90, Iss. 2, pp. e43-e56
Closed Access | Times Cited: 70
Dawn Marie R. Davis, Aaron M. Drucker, Ali Alikhan, et al.
Journal of the American Academy of Dermatology (2023) Vol. 90, Iss. 2, pp. e43-e56
Closed Access | Times Cited: 70
Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors
Richard W. Kim, Megan Lam, Katrina Abuabara, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 2, pp. 179-193
Closed Access | Times Cited: 19
Richard W. Kim, Megan Lam, Katrina Abuabara, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 2, pp. 179-193
Closed Access | Times Cited: 19
Dupilumab‐associated cutaneous adverse events among adult patients with atopic dermatitis: A retrospective study
Maddalena Napolitano, Gabriella Fabbrocini, Cataldo Patruno
The Journal of Dermatology (2023) Vol. 50, Iss. 7, pp. 880-887
Closed Access | Times Cited: 14
Maddalena Napolitano, Gabriella Fabbrocini, Cataldo Patruno
The Journal of Dermatology (2023) Vol. 50, Iss. 7, pp. 880-887
Closed Access | Times Cited: 14
Dupilumab in real-life settings: a review of adverse events and their pathogenesis
Elisa Camela, Anna Rita Giampetruzzi, Ornella De Pitá, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 4, pp. 439-447
Open Access | Times Cited: 5
Elisa Camela, Anna Rita Giampetruzzi, Ornella De Pitá, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 4, pp. 439-447
Open Access | Times Cited: 5
Exploring the Link Between Dupilumab and Cutaneous T-Cell Lymphomas: A Systematic Review
Leo Wan, Aileen Park, Peter Lio
Dermatitis (2025)
Closed Access
Leo Wan, Aileen Park, Peter Lio
Dermatitis (2025)
Closed Access
Adverse effects of biologics used to treat asthma
Andrea Sitek, Sergio E. Chiarella, Thanai Pongdee
Therapeutic Advances in Respiratory Disease (2025) Vol. 19
Open Access
Andrea Sitek, Sergio E. Chiarella, Thanai Pongdee
Therapeutic Advances in Respiratory Disease (2025) Vol. 19
Open Access
Mycosis Fungoides and Sézary Syndrome
Robert Gniadecki, Minakshi Taparia, Jean Deschênes, et al.
(2025), pp. 49-82
Closed Access
Robert Gniadecki, Minakshi Taparia, Jean Deschênes, et al.
(2025), pp. 49-82
Closed Access
Drug‐ and Vaccine‐Induced Cutaneous T‐Cell Lymphoma: A Systematic Review of the Literature
Ifa Etesami, Mahshid Sadat Ansari, Elnaz Pourgholi, et al.
Journal of Skin Cancer (2025) Vol. 2025, Iss. 1
Open Access
Ifa Etesami, Mahshid Sadat Ansari, Elnaz Pourgholi, et al.
Journal of Skin Cancer (2025) Vol. 2025, Iss. 1
Open Access
Eosinophilia and elevated IgE serum levels: a red flag: when your diagnosis is not a common atopic eczema or common allergy
Paulo Ricardo Criado, Hélio Amante Miot, Mayra Ianhez
Inflammation Research (2023) Vol. 72, Iss. 3, pp. 541-551
Closed Access | Times Cited: 10
Paulo Ricardo Criado, Hélio Amante Miot, Mayra Ianhez
Inflammation Research (2023) Vol. 72, Iss. 3, pp. 541-551
Closed Access | Times Cited: 10
Mycosis Fungoides and Sézary Syndrome: Microenvironment and Cancer Progression
Gábor Dobos, Ingrid Lazaridou, Adèle de Masson
Cancers (2023) Vol. 15, Iss. 3, pp. 746-746
Open Access | Times Cited: 10
Gábor Dobos, Ingrid Lazaridou, Adèle de Masson
Cancers (2023) Vol. 15, Iss. 3, pp. 746-746
Open Access | Times Cited: 10
An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma
Man Hu, Jörg Scheffel, Daniel Elieh Ali Komi, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4177-4197
Open Access | Times Cited: 9
Man Hu, Jörg Scheffel, Daniel Elieh Ali Komi, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4177-4197
Open Access | Times Cited: 9
Dupilumab for atopic dermatitis in metastatic cancer
J. Kenneth McClatchy, Gayle Ross
Australasian Journal of Dermatology (2024) Vol. 65, Iss. 5, pp. 472-475
Closed Access | Times Cited: 3
J. Kenneth McClatchy, Gayle Ross
Australasian Journal of Dermatology (2024) Vol. 65, Iss. 5, pp. 472-475
Closed Access | Times Cited: 3
Biologics Versus JAK Inhibitors. Part I: Cancer Risk. A Narrative Review
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 6, pp. 1389-1442
Open Access | Times Cited: 3
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 6, pp. 1389-1442
Open Access | Times Cited: 3
Cutaneous T cell lymphoma atlas reveals malignant TH2 cells supported by a B cell-rich tumor microenvironment
Ruoyan Li, Johanna Strobl, Elizabeth Poyner, et al.
Nature Immunology (2024) Vol. 25, Iss. 12, pp. 2320-2330
Open Access | Times Cited: 2
Ruoyan Li, Johanna Strobl, Elizabeth Poyner, et al.
Nature Immunology (2024) Vol. 25, Iss. 12, pp. 2320-2330
Open Access | Times Cited: 2
Combined Dupilumab and Allergen-Specific Immunotherapy in Severe Refractory Atopic Dermatitis
Jemin Kim, Jihee Boo, H. G. Jang, et al.
Allergy Asthma and Immunology Research (2024) Vol. 16, Iss. 6, pp. 682-682
Open Access | Times Cited: 2
Jemin Kim, Jihee Boo, H. G. Jang, et al.
Allergy Asthma and Immunology Research (2024) Vol. 16, Iss. 6, pp. 682-682
Open Access | Times Cited: 2
Angioimmunoblastic T-cell lymphoma unmasked by treatment with dupilumab
Zi-Yi Choo, Adesola A. Akinyemi, Thomas L. Cibull, et al.
JAAD Case Reports (2023) Vol. 33, pp. 87-90
Open Access | Times Cited: 4
Zi-Yi Choo, Adesola A. Akinyemi, Thomas L. Cibull, et al.
JAAD Case Reports (2023) Vol. 33, pp. 87-90
Open Access | Times Cited: 4
Candidate Gene Association Studies in Atopic Dermatitis in Participants of European and Asian Ancestry: A Systematic Review and Meta-Analysis
Alexandros Pontikas, Charalabos Antonatos, Evangelos Evangelou, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1456-1456
Open Access | Times Cited: 4
Alexandros Pontikas, Charalabos Antonatos, Evangelos Evangelou, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1456-1456
Open Access | Times Cited: 4
Paradoxical Psoriasis
Mariam Abdelghaffar, Sita Kottilil, Michael J. Murphy, et al.
Dermatologic Clinics (2024) Vol. 42, Iss. 3, pp. 471-480
Closed Access | Times Cited: 1
Mariam Abdelghaffar, Sita Kottilil, Michael J. Murphy, et al.
Dermatologic Clinics (2024) Vol. 42, Iss. 3, pp. 471-480
Closed Access | Times Cited: 1
Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System
Leore Lavin, Stephen W. Dusza, Shamir Geller
Journal of Investigative Dermatology (2024)
Closed Access | Times Cited: 1
Leore Lavin, Stephen W. Dusza, Shamir Geller
Journal of Investigative Dermatology (2024)
Closed Access | Times Cited: 1
Increased Risk of Cutaneous T‐Cell Lymphoma Development after Dupilumab Use for Atopic Dermatitis
Jenna Mandel, Jaanvi Mehta, R Häfer, et al.
Dermatologic Therapy (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
Jenna Mandel, Jaanvi Mehta, R Häfer, et al.
Dermatologic Therapy (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
Exploring the Association Between Atopic Dermatitis and Malignancy
David L Drum, Leo Wan, Anika Jallorina, et al.
Dermatologic Clinics (2024) Vol. 42, Iss. 4, pp. 625-634
Closed Access | Times Cited: 1
David L Drum, Leo Wan, Anika Jallorina, et al.
Dermatologic Clinics (2024) Vol. 42, Iss. 4, pp. 625-634
Closed Access | Times Cited: 1
Dupilumab-related late adverse events in patients with chronic rhinosinusitis with nasal polyps
Toshiyuki Matsuyama, Mizuki Sakurai, Kazuaki Chikamatsu
Acta Oto-Laryngologica (2024), pp. 1-4
Closed Access | Times Cited: 1
Toshiyuki Matsuyama, Mizuki Sakurai, Kazuaki Chikamatsu
Acta Oto-Laryngologica (2024), pp. 1-4
Closed Access | Times Cited: 1
Efficacité des biothérapies de l’asthme sévère sur les comorbidités allergiques
Charlotte Thibaut de Ménonville, L. Barakat, F. Laborier, et al.
Revue des Maladies Respiratoires (2024) Vol. 41, Iss. 9, pp. 669-679
Closed Access | Times Cited: 1
Charlotte Thibaut de Ménonville, L. Barakat, F. Laborier, et al.
Revue des Maladies Respiratoires (2024) Vol. 41, Iss. 9, pp. 669-679
Closed Access | Times Cited: 1
Dupilumab-Associated Mycosis Fungoides with a CD8+ Immunophenotype
Ariel Park, Lulu Wong, Annalise Lang, et al.
Dermatopathology (2022) Vol. 9, Iss. 4, pp. 385-391
Open Access | Times Cited: 6
Ariel Park, Lulu Wong, Annalise Lang, et al.
Dermatopathology (2022) Vol. 9, Iss. 4, pp. 385-391
Open Access | Times Cited: 6
Navigating the atopic dermatitis toolbox
Archana Samynathan, Jonathan I. Silverberg
Annals of Allergy Asthma & Immunology (2023) Vol. 132, Iss. 3, pp. 337-343
Closed Access | Times Cited: 3
Archana Samynathan, Jonathan I. Silverberg
Annals of Allergy Asthma & Immunology (2023) Vol. 132, Iss. 3, pp. 337-343
Closed Access | Times Cited: 3